Evinacumab Reduces Lipids, Cholesterol in Hypercholsterolemia and Hypertriglyceridemia
Data from a meta-analysis of evinacumab trials reveal significant reductions in cholesterol and other lipid markers among patients with dyslipidemia.
Source: hcplive.com